Safety and efficacy of direct versus conventional transfer to angiography suite in patients with severe acute stroke treated with thrombectomy (DIRECT ANGIO) in France: a multicentre, open-label, blinded-endpoint, randomised controlled trial.

Date publication

avril 2026

Journal

The Lancet. Neurology

Auteurs

Membres identifiés du Cancéropôle Est :
Pr GUILLEMIN Francis

Tous les auteurs :
Gory B, Maïer B, Pop R, Wolff V, Soize S, Moulin S, Consoli A, Lapergue B, Costalat V, Arquizan C, Marnat G, Sibon I, Lebedinsky AP, Vuillemet F, Blanc R, Sabben C, Veunac L, Bannier S, Richter JS, Castagnet H, Biondi A, Charbonnier G, Zhu F, Liao L, Anxionnat R, Cherifi A, Achit H, Guillemin F, Hossu G, Richard S,

Lien Pubmed

https://www.ncbi.nlm.nih.gov/pubmed/41864232

Résumé

Direct transfer to angiography suite (DTAS) for patients with suspected stroke primarily admitted to an endovascular-capable centre could accelerate in-hospital workflow and improve outcome. We aimed to assess the safety and efficacy of DTAS for patients with acute severe neurological deficit highly suggestive of ischaemic stroke due to a large vessel occlusion (ASND-LVO).

Mots clés

Humans, Female, Male, Aged, Thrombectomy, methods, France, Middle Aged, Aged, 80 and over, Treatment Outcome, Ischemic Stroke, surgery, Patient Transfer, methods, Cerebral Angiography, methods, Endovascular Procedures, methods

Référence

Lancet Neurol. 2026 04;25(4):346-356